FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

734452007: Saxagliptin hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3506885018 Saxagliptin hydrochloride (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3506886017 Saxagliptin hydrochloride en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Saxagliptin hydrochloride Is a Saxagliptin false Inferred relationship Existential restriction modifier
Saxagliptin hydrochloride Has disposition Dipeptidyl peptidase IV inhibitor true Inferred relationship Existential restriction modifier
Saxagliptin hydrochloride Is a Substance with alcohol structure true Inferred relationship Existential restriction modifier
Saxagliptin hydrochloride Is modification of Saxagliptin true Inferred relationship Existential restriction modifier
Saxagliptin hydrochloride Is a Substance with dipeptidyl peptidase IV inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Saxagliptin hydrochloride Is a Nitrile true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier 2
Onglyza 5mg tablets (Ethigen Ltd) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Ethigen Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (DE Pharmaceuticals) 30 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets 30 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Pharmaram Ltd) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Pharmaram Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Pharmaram Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Pharmaram Ltd) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (CST Pharma Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (CST Pharma Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (DE Pharmaceuticals) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (DE Pharmaceuticals) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (DE Pharmaceuticals) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (DE Pharmaceuticals) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (DE Pharmaceuticals) 56 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (DE Pharmaceuticals) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg tablets 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Waymade Healthcare Plc) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 850mg tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 850mg tablets 56 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Waymade Healthcare Plc) Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient True Saxagliptin hydrochloride Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start